Likewise, the combined impact of the DRR-ADARB1/ADAR/A3F mutations and age-A1 mRNA levels was also seen for indel signatures ID1, ID2, and ID7 in pancancer analyses as well as in certain cancers. This evidence concerns the gene ADAR and cancer.